Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon
Giorgio Bellati, Guido Colloredo, Luigi Roffi, Maurizio D'Aquino, Ferruccio Bonino, Gaetano Idéo, C.H.S.G.Volume:
26
Year:
1997
Language:
english
DOI:
10.1016/s0168-8278(97)80069-4
File:
PDF, 254 KB
english, 1997